Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EKF Diagnostics HoldingsLSE:EKF -0.58%52 Return-on-Tangible-Asset is 0.67% as of Dec. 2025, which is 92% below its 10-year median of 8.04. GuruFocus rates LSE:EKF with a GF Score™ of 52/100 and a GF Value™ of £0.28 (Fairly Valued). The stock has 4 warning signs investors should review. Among 855 Medical Devices & Instruments companies, EKF Diagnostics Holdings ranks better than 62.69% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. EKF Diagnostics Holdings's annualizedNet Income for the quarter that ended in Dec. 2025 was £0.36 Mil. EKF Diagnostics Holdings's average total tangible assets for the quarter that ended in Dec. 2025 was £53.45 Mil. Therefore, EKF Diagnostics Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2025 was 0.67%.
The historical rank and industry rank for EKF Diagnostics Holdings's Return-on-Tangible-Asset or its related term are showing as below:
LSE:EKF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -15.69 Med: 8.04 Max: 27.64
Current: 3.99
During the past 13 years, EKF Diagnostics Holdings's highest Return-on-Tangible-Asset was 27.64%. The lowest was -15.69%. And the median was 8.04%.
LSE:EKF's Return-on-Tangible-Asset is ranked better than 62.69% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 0.56
vs LSE:EKF: 3.99
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
EKF Diagnostics Holdings Return-on-Tangible-Asset Related Terms
EKF Diagnostics Holdings Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for EKF Diagnostics Holdings's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:EKF vs ABT, SYK, MDT: Return-on-Tangible-Asset Comparison
For the Medical Devices subindustry, EKF Diagnostics Holdings's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EKF Diagnostics Holdings Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EKF Diagnostics Holdings's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where EKF Diagnostics Holdings's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of 0.67% mean?
EKF Diagnostics Holdings (LSE:EKF) has a Return-on-Tangible-Asset of 0.67% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on EKF Diagnostics Holdings and its competitors. This is 92% below median its historical median of 8.04. According to the industry distribution chart, EKF Diagnostics Holdings ranks #319 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 37.3%.
Is EKF Diagnostics Holdings' Return-on-Tangible-Asset too high?
EKF Diagnostics Holdings' current Return-on-Tangible-Asset of 0.67% is 92% below median its 10-year median of 8.04. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.56. EKF Diagnostics Holdings' value of 0.67% is 19.6% above this industry median. Based on the distribution chart, EKF Diagnostics Holdings ranks #319 out of 855 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, EKF Diagnostics Holdings has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EKF Diagnostics Holdings' Return-on-Tangible-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, EKF Diagnostics Holdings ranks #319 out of 855 companies for Return-on-Tangible-Asset. This puts EKF Diagnostics Holdings in the upper half of its industry. The industry median Return-on-Tangible-Asset is 0.56. EKF Diagnostics Holdings' value of 0.67% is 19.6% above this benchmark. While the company's 10-year median is 8.04 vs. the industry median of 0.56, EKF Diagnostics Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.56, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EKF Diagnostics Holdings's current Return-on-Tangible-Asset of 0.67% is 19.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on EKF Diagnostics Holdings and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EKF Diagnostics Holdings's current Return-on-Tangible-Asset is 0.67%, which is 92% below median its own 10-year median of 8.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EKF Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, EKF Diagnostics Holdings (LSE:EKF) is currently considered Fairly Valued. The stock's GF Value™ is £0.28, compared to a current price of £0.26 — trading 8.8% below its estimated fair value. The current Return-on-Tangible-Asset is 0.67%, which is 92% below median its 10-year median of 8.04 and 19.6% above the Medical Devices & Instruments industry median of 0.56. EKF Diagnostics Holdings' overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For EKF Diagnostics Holdings (LSE:EKF), the current Return-on-Tangible-Asset is 0.67% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EKF Diagnostics Holdings (LSE:EKF) Overvalued in 2026?
Based on GuruFocus' analysis, EKF Diagnostics Holdings stock appears to be undervalued.
The current stock price of £0.26 is trading 8.8% below its estimated GF Value™ of £0.28.
GuruFocus considers EKF Diagnostics Holdings to be Fairly Valued.
Key valuation signals for LSE:EKF:
Return-on-Tangible-Asset: 0.67% (92% below median its 10-year median of 8.04)
GF Value™: £0.28 vs. price of £0.26 (8.8% below fair value)
Industry Position: 19.6% above the Medical Devices & Instruments median (#319 of 855)
No single metric tells the full story. See the LSE:EKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements.
52GF Score
Get the complete analysis for LSE:EKF
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:EKF has been successfully added to your 
